Home›Companies›Biotech & Pharma›TracerDX

TracerDX, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 8, 2024·Suggest an edit

About TracerDX

TracerDX is a private company based in New York, New York, incorporated in 2021 in Delaware. It has reported $7,894,996 raised in one offering on Form D since August 2024. Its chief executive is Mark Kaganovich.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 15, 2024Aug 8, 2024$7,894,996of $9.0M target18$438KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on TracerDX's Form D filed Aug 8, 2024.

MK
Mark Kaganovich
Chief Executive Officer and director

Sources

  1. SECTracerDX, Inc. filing history